We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$15B
AUM Growth
-$515M
Cap. Flow
-$1.49B
Cap. Flow %
-9.92%
Top 10 Hldgs %
31.73%
Holding
2,574
New
477
Increased
601
Reduced
825
Closed
586

Top Sells

Rank Stock Value
1
INDA icon
iShares MSCI India ETF
INDA
+$130M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$118M
3
AAPL icon
Apple
AAPL
+$98.7M
4
SHW icon
Sherwin-Williams
SHW
+$97.9M
5
CSX icon
CSX Corp
CSX
+$91.3M

Sector Composition

Rank Sector Weight
1 Industrials 11.73%
2 Technology 10.28%
3 Healthcare 7.87%
4 Consumer Discretionary 7.6%
5 Financials 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADT icon
2001
ADT
ADT
$5.42B
-23,518
Closed -$179K
ADUS icon
2002
Addus HomeCare
ADUS
$2.26B
-2,327
Closed -$270K
AEM icon
2003
Agnico Eagle Mines
AEM
$110B
-37,600
Closed -$2.46M
AFYA icon
2004
Afya
AFYA
$1.26B
-18,301
Closed -$323K
AGI icon
2005
Alamos Gold
AGI
$16B
-14,117
Closed -$221K
AGS
2006
DELISTED
PlayAGS
AGS
-80,000
Closed -$920K
AI icon
2007
C3.ai
AI
$1.57B
-69,982
Closed -$2.03M
AIN icon
2008
Albany International
AIN
$1.66B
-3,837
Closed -$324K
ALLK
2009
DELISTED
Allakos
ALLK
-32,800
Closed -$32.8K
ALLO icon
2010
Allogene Therapeutics
ALLO
$701M
-17,192
Closed -$40.1K
ALNY icon
2011
CALL
Alnylam Pharmaceuticals
ALNY
$31.6B
-30,000
Closed -$7.29M
ALT icon
2012
Altimmune
ALT
$605M
-22,738
Closed -$151K
OSG
2013
Octave Specialty Group
OSG
$204M
-21,102
Closed -$271K
AMED
2014
CALL
DELISTED
Amedisys
AMED
-12,600
Closed -$1.16M
AMP icon
2015
Ameriprise Financial
AMP
$49.6B
-839
Closed -$358K
AMPL icon
2016
Amplitude
AMPL
$1.64B
-11,313
Closed -$101K
AMSC icon
2017
American Superconductor
AMSC
$1.4B
-20,100
Closed -$470K
AMWL icon
2018
American Well
AMWL
$203M
-9,315
Closed -$60.5K
AN icon
2019
AutoNation
AN
$6.45B
-31,706
Closed -$5.05M
ANGL icon
2020
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.17B
-159,180
Closed -$4.5M
ARCB icon
2021
ArcBest
ARCB
$3.01B
-2,142
Closed -$229K
ARGX icon
2022
argenx
ARGX
$63.3B
-3,100
Closed -$1.33M
ARM icon
2023
Arm
ARM
$255B
-3,100
Closed -$507K
AROC icon
2024
Archrock
AROC
$5.38B
-143,432
Closed -$2.9M
ASAN icon
2025
Asana
ASAN
$2.25B
-11,196
Closed -$157K

Similar funds

Steve Schonfeld's Q3 2024 Portfolio in Review

As of Q3 2024, Steve Schonfeld held 2,574 positions worth $15B, down 3.3% from $15.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Steve Schonfeld withdrew a net $1.49B in Q3 2024, closing 586 positions and reducing 825 holdings. Its most notable exit was Rogers Communications, an estimated $47.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Steve Schonfeld opened a new position in iShares MSCI Emerging Markets ETF worth $60.2M.

  • Steve Schonfeld's largest Q3 2024 buy was iShares MSCI Emerging Markets ETF: 1,312,275 shares worth $60.2M.
  • Steve Schonfeld added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $1.11B increase.
  • Steve Schonfeld's biggest Q3 2024 reduction was iShares MSCI India ETF, cutting an estimated $130M.
  • Steve Schonfeld fully exited Rogers Communications in Q3 2024, selling an estimated $47.5M.
  • Steve Schonfeld's ten largest holdings make up 32% of its $15B portfolio in Q3 2024.
  • Steve Schonfeld opened 477 new positions and closed 586 in Q3 2024.
  • Steve Schonfeld's portfolio value fell 3.3% quarter-over-quarter to $15B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.